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Objectives. This study investigated whether maximal exercise
performance can be improved by acutely decreasing the work of
breathing in these patients.
Background. Exertional dyspnea is a frequent limiting symp-
tom in patients with heart failure. It may result from increased
work of breathing.
Methods. Fifteen patients with heart failure and nine age-
matched normal subjects underwent two maximal exercise tests.
Subjects exercised twice in randomized, single-blind manner
using room air (RA) and a 79% helium/21% oxygen mixture (He).
Respiratory gas analysis, Borg scale recordings of perceived
dyspnea and near infrared spectroscopy of an accessory respira-
tory muscle were obtained during exercise.
Results. In normal subjects there was no significant difference
in peak oxygen uptake (VO2) ([mean6 SD] RA 386 8 vs. He 356
7 ml/kg per min), exercise duration (RA 724 6 163 vs. He 762 6
123 s) or peak minute ventilation (RA 97 6 27 vs. He 97 6 28
liters/min, all p5NS). Only three of nine control subjects thought
that exercise with the He mixture was subjectively easier. In
contrast, patients with heart failure exercised an average of 146 s
longer with the He mixture (RA 8686 293 vs. He 1,0146 338, p <
0.01). Peak VO2 (RA 196 4 vs. He 186 5 ml/kg per min) and peak
minute ventilation (RA 53 6 12 vs. He 53 6 15 liters/min) were
unchanged (both p 5 NS). The respiratory quotient at peak
exercise was lower with the He mixture (RA 1.05 6 0.08 vs. He
0.98 6 0.06, p < 0.05). Thirteen of the 15 patients thought that
exercise with the He mixture was subjectively easier (p < 0.02 vs.
control group).
Conclusions. In patients with heart failure, pulmonary factors,
including respiratory muscle work and airflow turbulence, con-
tribute to limiting exercise performance. Therapeutic interven-
tions aimed at attenuating work of breathing may be beneficial.
(J Am Coll Cardiol 1997;29:590–6)
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In patients with heart failure, changes in pulmonary function
occur as a consequence of chronic venous pulmonary hyper-
tension. This abnormal hemodynamic function results in de-
creased lung compliance and an increase in airflow resistance,
both of which are major components of the work of breathing
(1–3). During exercise, the work of breathing is further in-
creased because of the excessive ventilatory response, with a
further increase in pulmonary pressures. Previous studies (4,5)
have demonstrated an increase in the metabolic cost of breath-
ing in patients with heart failure at rest and during exercise
compared with that in normal control subjects. This elevated
work of breathing probably contributes to the exertional
dyspnea so characteristic of these patients.
Although exertional dyspnea is a major clinical symptom
in these patients, it is presumed that exercise is limited by
central or peripheral factors and not lung function. However,
some previous studies (6,7) have suggested a pulmonary
limitation to maximal exercise performance in some patients
with heart failure. Cabanes et al. (7) demonstrated an improve-
ment in both submaximal and maximal exercise performance
after inhalation of methoxamine in patients with heart failure
limited by dyspnea, presumably by a decrease in airflow
resistance. Selective respiratory muscle function has also
been shown (8) to improve exercise performance in these
patients.
In the present study, we investigated the effect of acutely
unloading the work of the respiratory muscles on exercise
capacity and the sensation of dyspnea in patients with heart
failure. We accomplished this by exercise using helium, an
inert, nonabsorbable gas with a density 70% less than that of
room air (9,10). Although helium is 10%more viscous than air,
its lower density has been shown (9,10) to decrease airflow
turbulence in both the large and small bronchial airways by
maintaining laminar flow. We hypothesized that if exercise
performance was limited in part by the metabolic costs of
breathing, then exercise capacity would be improved during
exercise with the normoxic helium mixture in patients with
heart failure. Similarly if dyspnea were predominantly a con-
sequence of the work of breathing, then the sensation of
dyspnea during exercise would also be less.
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Methods
Patients. Fifteen patients with heart failure participated in
the study (13 men, 2 women; mean [6 SD] age 52 6 10 years,
range 37 to 62; mean left ventricular ejection fraction 19 6
11%). Twelve patients had cardiomyopathy, and only three
had coronary artery disease. Body surface area averaged
1.88 6 0.19 m2.
Nine age-matched control subjects (three women, six men,
mean age 49 6 13 years, range 41 to 53) also participated.
Body surface area was 1.87 6 0.23 m2. Both groups were
comparable with regard to height and weight.
Standard pulmonary function tests, including lung volumes,
flow rates and respiratory muscle strength, were performed in
all subjects. Forced expired volume in 1 s divided by forced
expired volume was comparable between the heart failure
group and normal subjects. Respiratory muscle strength
tended to be lower in patients with heart failure, although this
did not achieve statistical significance (Table 1). Respiratory
muscle strength was assessed by measuring maximal mouth
pressures. Maximal inspiratory pressure was measured at
residual volume, whereas maximal expiratory pressure was
assessed at total lung capacity. Maximal inspiratory and expi-
ratory pressures were recorded in triplicate or until a stable
value was achieved (11).
The protocol was approved by the Human Studies Com-
mittee at Columbia Presbyterian Hospital. Written informed
consent was obtained from all subjects.
Study protocol. Maximal symptom-limited treadmill exer-
cise tests were performed twice in a 1-week period in random-
ized, single-blinded fashion. One test was performed using
room air and the other a normoxic helium mixture (79%
helium/21% oxygen). Patients exercised according to the mod-
ified Naughton protocol and control subjects by the Bruce
protocol. All subjects had undergone a previous exercise test.
Subjects reported to the exercise laboratory in the fasting
state. Near infrared light guides were applied to the sixth right
intercostal space over the serratus anterior muscle to monitor
accessory respiratory muscle oxygenation. Subjects were con-
nected to a metabolic cart (Medical Graphics Cardio O2)
through a disposable pneumotach. Metabolic measurements,
heart rate, blood pressure and pulse oximetry were monitored
throughout exercise. Borg scale recordings of perceived dys-
pnea were obtained during the last minute of each work load
and at the end of exercise. At the completion of both studies,
the subject was asked which test, if any, was easier.
The metabolic cart was calibrated for volumetric analysis
before the exercise tests using either room air or helium. The
density of helium is 0.43 mg/liter standard temperature and
pressure, dry (STPD). In contrast, the density of room air is
1.12 mg/liter STPD.
The normoxic helium mixture was connected by a quick
release valve to a 100-liter Douglas bag fitted with two Hans
Rudolph valves connected in series to a third Hans Rudolph
valve coupled to a disposable pneumotach. The expired gas
was vented into the atmosphere. This experimental design was
used for both exercise tests, with a sham setup used during the
room air test. Subjects were not permitted to speak during
testing or 2 min into recovery because of the change in the
tonal quality of the voice with helium.
Near infrared spectroscopy. Accessory respiratory muscle
oxygenation was monitored using near infrared spectroscopy.
We previously used this technique to noninvasively monitor
skeletal muscle oxygenation (12–15). Both oxygenated and
deoxygenated hemoglobin absorb light at 850 nm, whereas
primarily deoxygenated hemoglobin absorbs light at 760 nm.
Therefore, by monitoring the difference in absorption noted
at these two wavelengths, it is possible to assess changes in
hemoglobin oxygenation. The difference in absorption at 760
to 850 nm was used to assess serratus anterior muscle oxygen-
ation. All studies were performed using the same gain set-
tings on the spectrometer. Absorption changes were then
expressed as arbitrary units of deviation from a stable baseline.
The higher the arbitrary unit, the greater the muscle deoxy-
genation. A negative value represents an increase in oxygen-
ation.
Statistical analysis. Data from patients and normal sub-
jects were compared with Student paired or unpaired t tests, as
appropriate. Relation between variables were examined by
linear regression analysis. Chi-square analysis was used to
examine nonnumeric differences between groups. A value of
p , 0.05 was considered significant. Data are expressed as
mean value 6 SD.
Results
Exercise tests. The results of metabolic and ventilatory
measurements for the normal subjects and patients with heart
failure are shown in Table 2 and Figure 1. During rest, the
respiratory quotient was significantly lower during helium (He)
inhalation in both normal subjects (room air [RA] 0.81 6 0.05
vs. He 0.74 6 0.04, p , 0.05) and patients with heart failure
(RA 0.84 6 0.08 vs. He 0.76 6 0.05, p , 0.05). No other
hemodynamic, metabolic or ventilatory variable was affected
Abbreviations and Acronyms
He 5 79% helium/21% oxygen mixture
RA 5 room air
STPD 5 standard temperature and pressure, dry
VO2 5 oxygen uptake
Table 1. Pulmonary Function Tests in Normal Subjects and Patients
With Heart Failure
Normal Group
(mean 6 SD)
CHF Group
(mean 6 SD)
FEV1/FVC (%) 78 6 6 73 6 6
Maximal inspiratory pressure (kPa) 40 6 9 36 6 12
Maximal expiratory pressure (kPa) 58 6 15 50 6 10
FEV1 5 forced expiratory volume in 1 s; FVC 5 forced vital capacity.
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by helium inhalation. The inspiratory duty cycle (i.e., the time
in inspiration divided by the total time per breath) was similar
during helium inhalation in both normal subjects (RA 0.49 6
0.05 vs. He 0.506 0.08, p5 NS) and patients with heart failure
(RA 0.45 6 0.03 vs. He 0.45 6 0.03, p 5 NS).
With exercise, peak oxygen uptake (VO2) and minute
ventilation remained unchanged in both tests in normal sub-
jects and patients with heart failure. As with the rest data, the
respiratory quotient at end-exercise was significantly lower
during helium inhalation in both groups. In normal subjects,
the respiratory quotient was reduced from 1.18 to 1.11 and
from 1.05 to 0.98 in patients with heart failure (both p , 0.05).
The duty cycle at peak exercise was not significantly different in
normal subjects (RA 0.48 6 0.02 vs. He 0.47 6 0.02, p 5 NS)
and patients with heart failure (RA 0.45 6 0.03 vs. He 0.45 6
0.03, p 5 NS).
Exercise duration measured in seconds for the individual
subjects is shown in Figure 2. The exercise duration in normal
subjects remained unchanged (D 1 38 6 66 s). However, in
patients with heart failure, a significant increase in exercise
duration was observed. Exercise duration increased an average
of 2.4 min, from 869 to 1,013 s (D 1 144 6 147 s).
Near infrared spectroscopy. Minimal 760- to 850-nm ab-
sorption occurred during exercise in normal subjects. Near
infrared data from a normal subject during exercise using room
air and helium is illustrated in Figure 2. The 760- to 850-nm
signal (i.e., the difference signal) shows minor changes with
exercise.
In contrast, patients with heart failure demonstrated sus-
tained accessory respiratory muscle deoxygenation with exer-
cise that was ameliorated with exercise with helium (Fig. 3).
When the 760- to 850-nm deflection was quantitated in arbi-
trary units, the maximal deflection for the patients with heart
failure tended to be lower at peak exercise during the helium
test, but this did not achieve statistical significance. However, if
the near infrared signal is recorded at the same time point (i.e.,
maximal exercise duration of the test using room air), then
accessory muscle deoxygenation is significantly reduced during
the helium study (Fig. 4).
Ratings of perceived dyspnea. Perceived dyspnea at each
level of exercise in the patients with heart failure during
exercise with room air and the normoxic helium mixture is
illustrated in Figure 5. Although perceived dyspnea tended to
be lower with helium inhalation, these curves were not statis-
tically different. However, 13 of the 15 patients with heart
failure stated that the exercise test with helium was signifi-
cantly easier than that with room air, whereas only three of the
nine normal subjects were able to detect a difference (p ,
0.05). Six of the patients were limited by dyspnea during
exercise with room air; however, only two patients remained
limited by dyspnea during the helium study (p 5 NS).
Table 2. Hemodynamic, Metabolic and Ventilatory Response to Exercise in Normal Subjects and Patients With Heart Failure Breathing
Room Air and Helium During Rest and Exercise
Rest Exercise
RQ
Borg
Dyspnea Fatigue
Exercise
Duration
(s)
HR
(beats/min)
Mean BP
(mm Hg)
VO2
(ml/kg
per min)
VE
(liters/min) RQ
HR
(beats/min)
Mean BP
(mm Hg)
VO2
(ml/kg
per min)
VE
(liters/min)
Normal subjects
Room air 826 15 956 11 5.96 1.1 136 3 0.816 0.05 1746 9 976 16 38.56 8.1 986 28 1.186 0.07 166 3 156 3 7246 163
Helium 786 11 936 13 5.16 1.2 136 2 0.746 0.04* 1756 7 1036 9 35.16 7.4 976 28 1.116 0.11* 176 1 186 2 7626 123
HF group
Room air 866 14 826 13 5.76 1.2 146 3 0.846 0.08 1316 21 866 18 18.96 4.4 536 12 1.056 0.08 156 3 166 3 8686 294
Helium 866 14 866 14 5.76 1.8 136 3 0.766 0.05* 1366 19 886 18 18.06 4.7 536 15 0.986 0.06* 156 3 166 3 1,0146 338*
*p , 0.05 room air versus helium. Data presented are mean value 6 SD. BP 5 blood pressure; HF 5 heart failure; HR 5 heart rate; RQ 5 respiratory quotient;
VE 5 minute ventilation; VO2 5 oxygen consumption.
Figure 1. Exercise duration during exercise with room air and helium
in the individual normal subjects and patients with heart failure.
CHF 5 congestive heart failure.
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Discussion
In the present study, we demonstrated that in normal
subjects, acute unloading of the work of breathing using a
normoxic helium mixture minimally affected exercise perfor-
mance. Peak VO2, exercise duration and the sensation of
dyspnea during exercise was unaffected in normal subjects.
These findings support a cardiovascular limitation to exercise
performance in normal humans. In contrast, in patients with
heart failure there was a significant increase in exercise dura-
tion, a subjective decrease in exertional dyspnea and a lessen-
ing of accessory respiratory muscle deoxygenation. Therefore,
in patients with heart failure, pulmonary factors appear to
contribute to the limitation of peak exercise performance.
Exercise response to helium. Previous investigators have
examined the exercise response of normal healthy adults while
breathing a normoxic helium mixture (16–18). Some investi-
gators have demonstrated an increase in exercise ventilation
and peak VO2 in young healthy subjects, whereas others have
not found any improvement in exercise performance. In our
study, we were unable to demonstrate any improvement in
exercise performance in the normal subjects while inhaling the
normoxic helium mixture. Unlike some of the previous studies,
we did not humidify the helium/oxygen mixture, which may
have contributed to our inability to detect any significant
differences. However it is more likely that in the absence of
significant pulmonary pathology, exercise performance is not
affected by the inhalation of a lighter density gas.
In patients with obstructive lung disease who exhibit an
increased resistance to airflow, exercise performance may be
improved using helium/oxygen mixtures. Improvement in rest
indexes of lung function have been shown in some studies
(19–21). However, Bradley et al. (20) demonstrated no im-
provement in submaximal exercise performance in 7 patients
with advanced chronic obstructive pulmonary disease. Simi-
larly, Martin et al. (21) failed to demonstrate any improvement
in peak VO2, maximal minute ventilation or exercise duration
in 11 pediatric patients with cystic fibrosis despite an improve-
ment in resting spirometry. Estimates of perceived dyspnea
were not obtained during those studies (21).
Similar to previous studies, we did not demonstrate an
improvement in peak VO2 or peak minute ventilation during
exercise with the normoxic helium mixture in patients with
heart failure. However, we were able to demonstrate a signif-
icant improvement in exercise duration as well as a subjective
decrease in the overall sensation of dyspnea during exercise in
these patients. Our ability to detect this may have been related
to differences in the exercise protocols. We used a steady state
protocol rather than rapid incremental protocols (20,21).
Possible mechanisms. There are several possible explana-
tions for the improved exercise performance in the patients
with heart failure. Improvement could result as a consequence
of decreased lung work from the lower density gas mixture.
Although the work of breathing was not directly measured,
minute ventilation during the exercise with room air and with
Figure 2. Near infrared absorption
spectra during exercise with room
air and helium in a normal subject.
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the normoxic helium mixture was similar. Given the substantial
differences in gas density of the two gases, work of breathing
must have been reduced. Besides a simple mass effect, the
improvement in exercise performance may have resulted from
a decrease in airflow turbulence, with subsequent decrease in
airflow resistance and work of breathing. Previously, Cabanes
et al. (6) demonstrated bronchial hyperresponsiveness second-
ary to metacholine challenge in patients with heart failure. This
bronchial hyperresponsiveness could be prevented by pretreat-
ment with methoxamine. Pretreatment with methoxamine
improved submaximal and maximal exercise performance in
patients with heart failure limited by dyspnea. Cabanes et al.
hypothesized that the improvement in exercise performance
was related to a diminished airflow resistance. Our findings are
concordant with these previous studies. Furthermore, our
study extends the findings of Cabanes et al. because our study
was not limited to patients who terminated exercise specifically
from dyspnea.
Another possible hypothesis to explain our results could be
Figure 3. Near infrared absorption spectra during
exercise with room air and helium in a patient with
heart failure. CHF 5 congestive heart failure.
Figure 4. Bar graphs demonstrating 760- to 850-nm absorption in
arbitrary units for patients with heart failure at end-exercise during
inhalation of room air and at 850 s from the start of exercise and at
peak exercise during inhalation of helium.
Figure 5. Comparison of perceived dyspnea at each level of treadmill
exercise during exercise with room air and helium in patients with
heart failure.
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that with a decrease in the work of breathing, there is a
shunting of blood from the lungs to the exercising limbs. In
several previous studies, we demonstrated accessory respira-
tory muscle deoxygenation during exercise in patients with
congestive heart failure from systolic dysfunction and valvular
disease. In the latter study, after mitral valvuloplasty with a
significant increase in valve area, respiratory muscle deoxygen-
ation was attenuated. In the present study, we again demon-
strated a progressive, sustained increase in respiratory muscle
deoxygenation during exercise in the patients with heart fail-
ure. Peak 760- to 850-nm absorption tended to be lower during
exercise with the normoxic helium mixture and was signifi-
cantly reduced at comparable time points during exercise. This
may represent a shift in blood flow such that more cardiac
output is available to the limb musculature. This proposed shift
in blood flow distribution could result in the ability to perform
more work. The lessening of accessory respiratory muscle
deoxygenation during exercise in patients with heart failure
supports this theory, although without leg flow measurements
this remains purely speculative. The lower respiratory quotient
at end-exercise in the patients with heart failure also suggests
that less anaerobic work is being performed by the respiratory
muscles and all working muscles.
Although patients with heart failure were able to accurately
distinguish between the two gas mixtures and consistently
report a greater alleviation of dyspnea, this subjective change
could not be quantitated during exercise by use of the Borg
scale. This unidimensional measure was probably not sensitive
enough to capture the qualitative difference perceived by the
patients. One of the most difficult challenges in clinical medi-
cine has been to design an adequate tool that assesses dyspnea.
The great number of approaches to quantitating dyspnea
implies that there is no ideal measurement for this multidi-
mensional sensation.
Study limitations. A major limitation of the study was the
single-blinded design. The investigator could have subcon-
sciously encouraged the patient more when the helium/oxygen
mixture was administered. However, the normoxic helium
mixture was delivered through a closed system that required
careful surveillance to ensure consistent delivery of the gas. At
high work loads, the gas reservoir would be rapidly exhausted,
thus, the investigators’ tendency was to terminate exercise
sooner rather than later because of anxiety over possible
inadequate gas delivery.
This study is also limited in that work of breathing mea-
surements were not obtained during the exercise tests. How-
ever, by simple mass effects as well as probable decreases in
airflow resistance in both groups, the work of breathing should
be less.
Our results may have been underestimated because the
patients studied were limited by both exertional dyspnea and
fatigue. Had we selected patients limited primarily by exer-
tional dyspnea, we might have detected greater improvement
during testing with the normoxic helium mixture.
Our failure to humidify the gas mixture may have also
negatively affected our results because bronchoconstriction can
be caused by the dryness of the gas. However, this would have
a similar effect in both patients with heart failure and normal
subjects.
Clinical implications. In patients with heart failure, the
metabolic costs of breathing affects exercise performance.
During exercise with the normoxic helium mixture where the
work of breathing is less, patients can perform more exercise.
Thus, in these patients there appears to be a pulmonary
limitation to peak exercise performance. Alternatively, with a
reduced work of breathing, blood flow may be redistributed to
the limb muscles rather than the ventilatory muscles. More
work can be performed at the same oxygen cost. Therapeutic
approaches directed at reducing the work of breathing should
improve exercise performance in these patients. Aggressive
diuresis with significant reduction in lung water should and
does improve both submaximal and maximal exercise perfor-
mance. Bronchodilation with beta-agonists that decrease air-
flow resistance similarly should and does improve submaximal
and maximal exercise performance (22). Finally, in patients
with marked end-stage heart failure who are receiving treat-
ment with home oxygen therapy, a normoxic helium mixture
may provide greater relief.
In this study we also observed that the sensation of dyspnea
in patients with heart failure is only slightly modified by acutely
decreasing ventilatory muscle work. Previous studies (23) in
posttransplant recipients have revealed an alleviation of exer-
tional dyspnea despite an absence of reduction in diaphrag-
matic work. We also showed (24) in a small group of patients
that selective respiratory muscle training ameliorates exer-
tional dyspnea but does not diminish the work of breathing.
Thus, all these studies suggest that ventilatory muscle work is
not the predominant signal for the sensation of dyspnea. Other
mechanisms, such as chemoreceptor activation, airflow resis-
tance or muscle perfusion, alone or in combination, may be the
primary determinant for this sensation.
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